Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Balveen Kaur is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
-
Oncolytic HSV Cancer Therapy: Enhancement by Vasculostatin Gene Therapy
Project: Research project
-
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
Kaur, B., CHIOCCA, A., Caligiuri, M., Fernandez, S., GLORIOSO, J., GOINS, W., KAUR, B., LIGON, K. L., Caligiuri, M., CHIOCCA, A., GLORIOSO, J., GOINS, W., Nakano, I. & Yu, J.
Project: Research project
-
Ohio State Neuroscience Center Core
Kaur, B., BEATTIE, C., BROWN, A., MCTIGUE, D., NELSON, R., OBERDICK, J., OBRIETAN, K., YOUNG, A. & ZHU, M.
Project: Research project
-
-
Oncolytic virus-mediated target delivery of a therapeutic antibody fragment in glioblastoma
Kaur, B. & CARBONELL, A.
Project: Research project
-
Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus (Journal of Ovarian Research, (2022), 15, 1, (130), 10.1186/s13048-022-01054-5)
Saini, U., Smith, B. Q., Dorayappan, K. D. P., Yoo, J. Y., Maxwell, G. L., Kaur, B., Konishi, I., O’Malley, D., Cohn, D. E. & Selvendiran, K., Dec 2023, In: Journal of Ovarian Research. 16, 1, 38.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
PKR induces TGF-β and limits oncolytic immune therapy
Hong, B., Sahu, U., Mullarkey, M. P., Hong, E., Pei, G., Yan, Y., Otani, Y., Banasavadi-Siddegowda, Y., Fan, H., Zhao, Z., Yu, J., Caligiuri, M. A. & Kaur, B., Feb 16 2023, In: Journal for ImmunoTherapy of Cancer. 11, 2, e006164.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Histone modifiers at the crossroads of oncolytic and oncogenic viruses
Murphy, S. A., Mapes, N. J., Dua, D. & Kaur, B., Jun 1 2022, In: Molecular Therapy. 30, 6, p. 2153-2162 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors
Anami, Y., Otani, Y., Xiong, W., Ha, S. Y. Y., Yamaguchi, A., Rivera-Caraballo, K. A., Zhang, N., An, Z., Kaur, B. & Tsuchikama, K., May 24 2022, In: Cell Reports. 39, 8, 110839.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme
Arunachalam, E., Rogers, W., Simpson, G. R., Möller-Levet, C., Bolton, G., Ismael, M., Smith, C., Keegen, K., Bagwan, I., Brend, T., Short, S. C., Hong, B., Otani, Y., Kaur, B., Annels, N., Morgan, R. & Pandha, H., Dec 2022, In: BMC Cancer. 22, 1, 400.Research output: Contribution to journal › Article › peer-review
Open Access